Cargando…
How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in mice
The PI3K/Akt signaling pathway is frequently hyperactivated in different types of breast cancer. In the past two decades, major efforts have been made to develop inhibitors of this pathway to treat cancer patients. However, the most evolutionarily conserved function of this pathway is in cellular an...
Autor principal: | Hay, Nissim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107625/ https://www.ncbi.nlm.nih.gov/pubmed/35578699 |
Ejemplares similares
-
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice)
por: Wang, Qi, et al.
Publicado: (2017) -
Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation
por: Nogueira, Veronique, et al.
Publicado: (2018) -
Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT Pathway
por: An, Xin, et al.
Publicado: (2020) -
Akt2: a role in breast cancer metastasis
por: Chau, Noan-Minh, et al.
Publicado: (2004) -
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
por: Lote, Hazel, et al.
Publicado: (2018)